SPX4,241.66-42.08 -0.98%
DIA338.14-1.78 -0.52%
IXIC12,744.65-220.69 -1.70%

BRIEF-Quoin Pharmaceuticals Announces Receipt Of Constructive Scientific Advice From EMA For QRX003 Development In Europe

BRIEF-Quoin Pharmaceuticals Announces Receipt Of Constructive Scientific Advice From EMA For QRX003 Development In Europe

Reuters · 07/28/2022 08:40
BRIEF-Quoin Pharmaceuticals Announces Receipt Of Constructive Scientific Advice From EMA For QRX003 Development In Europe

- Quoin Pharmaceuticals Ltd QNRX:

  • QUOIN PHARMACEUTICALS ANNOUNCES RECEIPT OF CONSTRUCTIVE SCIENTIFIC ADVICE FROM EMA FOR QRX003 DEVELOPMENT IN EUROPE

  • QUOIN PHARMACEUTICALS LTD - SCIENTIFIC ADVICE WAS RECEIVED IN RESPONSE TO A BRIEFING SUBMISSION DOCUMENT FILED BY QUOIN TO EMA ON MAY 26, 2022

  • QUOIN PHARMACEUTICALS LTD - CONTINUE TO EXPAND OUR NETWORK OF SUPPLY AND DISTRIBUTION AGREEMENTS FOR QRX003

Source text for Eikon: ID:

Further company coverage: [QNRX]